Search - tctmd.com

Displaying 161 - 180 of 5033

Sort: Relevancy | Date

Presentation TCT 2024

Summary and Next Steps

Presenter: NULL

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Optimizing TAVI Through Standardized Invasive Hemodynamics

Presenter: Ravi Ramana

October 30, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 30, 2024

Presentation TCT 2024

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Presenter: Frederic Bouisset

October 30, 2024

Presentation TCT 2024

Magic Touch

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Selution

Presenter: Simon Eccleshall

October 30, 2024

Presentation TCT 2024

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 30, 2024

Presentation TCT 2024

Case: Complex PAD Case

Presenter: Sonal Pruthi

October 30, 2024

Presentation TCT 2024

Case: Complex Illiac Case

Presenter: Hillary Johnston-Cox

October 30, 2024

Presentation TCT 2024

Case: Complex CLTI Case

Presenter: Fadi Saab

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

October 30, 2024

Presentation TCT 2024

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Presenter: Aniket Venkatesh

October 30, 2024

Presentation TCT 2024

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

Presenter: NULL

October 30, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Advertisement

Summary and Next Steps

How to Manage After TTVI?

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

A Closer Look at the ACURATE IDE Study

Optimizing TAVI Through Standardized Invasive Hemodynamics

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Magic Touch

Selution

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

Case: Complex PAD Case

Case: Complex Illiac Case

Case: Complex CLTI Case

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content